InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,316.15
(
0.15%
)
US TECH 100
18,202.00
(
0.03%
)
Dow Jones
39,847.23
(
0.10%
)
Brent Oil
83.06
(
-0.57%
)
Bitcoin
69,767.44
(
-2.35%
)
Post# of 4273
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: Johnny Bee Good post# 2128

Thursday, 01/19/2017 8:12:32 PM

Thursday, January 19, 2017 8:12:32 PM

Post# of 4273
It's a bit premature for congratulations. The stock didn't exactly take off on the news.
The differentiation with Linzess was the tolerability/safety. The FDA somehow managed to put a damper on that.
This should probably be the first in class drug everyone tries first. The problem is a lot of physicians are going to be influenced by the label.
Maybe the company will decide they have to partner or sell now.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up